目的 探讨药学部利用企业微信为门诊癌痛患者提供药学服务的效果。 方法 收集2020年1月1日至2023年1月30日苏州大学附属第一医院门诊收治的首次和/或既往接受癌痛相关药物治疗的患者资料进行回顾性研究，按是否使用企业微信接受门诊癌痛药学服务将患者分为常规药学服务管理组（常规组）和企业微信模式药学服务管理组（企业微信组）。记录2组患者处方达标情况，经过治疗后癌痛程度及患者生活质量评价指标（包括生理机能、生理职能、躯体疼痛、精力、社会功能、情感职能、精神健康及总体健康等8个维度）的变化情况。 结果 共纳入符合标准的患者174例，常规组和企业微信组各87例。2组患者年龄、性别等一般资料差异无统计学意义（均P>0。05）。进行企业微信管理前，2组患者经止痛治疗后处于无痛、轻度疼痛、中度疼痛和重度疼痛的患者占比差异无统计学意义（均P>0。05）。常规组87例患者中处方不达标者13例，不达标率14。9%；企业微信组87例患者中处方不达标者2例，不达标率2。3%；组间比较差异有统计学意义（χ2=8。828，P<0。05）。实施企业微信管理后，企业微信组疼痛评分为无痛的患者数由19例增加到55例（63。2%），常规组由18例增加到41例（47。1%），企业微信组无痛者占比高于常规组，差异有统计学意义（χ2=4。555，P=0。033）。在进行企业微信管理前，2组患者生活质量各项指标的评分差异无统计学意义（均P>0。05）；经企业微信管理后，企业微信组患者的生活质量8个维度的评分均高于常规组，差异均有统计学意义（均P<0。05）。 结论 使用企业微信进行药学服务可改善癌痛患者的治疗效果，提高癌痛患者的生活质量，有助于提高药学服务质量，有一定的推广与利用价值。 Objective To explore the effects of pharmaceutical services through enterprise WeChat for outpatients with cancer pain。 Methods A retrospective study was conducted on patients who were first diagnosed and/or previously treated for cancer pain and visited Outpatient Department of the First Affiliated Hospital of Soochow University from January 1， 2020 to January 30， 2023。 The outpatients were divided into conventional pharmaceutical services management group (conventional group) and pharmaceutical services management group through enterprise WeChat (enterprise WeChat group) based on whether they received pharmaceutical services for cancer pain through enterprise WeChat。 Prescription appropriateness， changes in cancer pain and life quality evaluation indicators after treatment in patients between the 2 groups were recorded and compared。 Results A total of 174 patients were included， with 87 patients in each group。 There were no significant differences in age and gender between the 2 groups (all P>0。05)。 Before the pharmaceutical services management for cancer pain through enterprise WeChat， the differences in the proportion of patients with pain free， mild， moderate， and severe pain after pain relief treatments between the 2 groups were not significant (all P>0。05)。 In the conventional group， 13 out of 87 patients (14。9%) had inappropriate prescriptions， and 2 out of 87 (2。3%) in the enterprise WeChat group， with statistically significant difference (χ2=8。828， P<0。05)。 After management with enterprise WeChat， the patients of pain-free increased from 19 to 55 (63。2%) in the enterprise WeChat group， and from 18 to 41 (47。1%) in the conventional group。 The difference in the proportion of pain-free patients between the 2 groups was statistically significant (χ2=4。555， P=0。033)。 The differences in the scores of various indicators of life quality between the 2 groups before management with enterprise WeChat were not significant (all P>0。05)。 After the management with enterprise WeChat， life quality scores in all the 8 dimensions were significantly higher than those in the conventional group (all P<0。05)。 Conclusion The utilization of enterprise WeChat could improve the treatment effect of cancer pain， enhance their life quality， help improve the quality of pharmaceutical services， and have certain promotion and utilization value。
Analysis of effectiveness of pharmaceutical services using enterprise WeChat for outpatients with cancer pain
Objective To explore the effects of pharmaceutical services through enterprise WeChat for outpatients with cancer pain. Methods A retrospective study was conducted on patients who were first diagnosed and/or previously treated for cancer pain and visited Outpatient Department of the First Affiliated Hospital of Soochow University from January 1, 2020 to January 30, 2023. The outpatients were divided into conventional pharmaceutical services management group (conventional group) and pharmaceutical services management group through enterprise WeChat (enterprise WeChat group) based on whether they received pharmaceutical services for cancer pain through enterprise WeChat. Prescription appropriateness, changes in cancer pain and life quality evaluation indicators after treatment in patients between the 2 groups were recorded and compared. Results A total of 174 patients were included, with 87 patients in each group. There were no significant differences in age and gender between the 2 groups (all P>0.05). Before the pharmaceutical services management for cancer pain through enterprise WeChat, the differences in the proportion of patients with pain free, mild, moderate, and severe pain after pain relief treatments between the 2 groups were not significant (all P>0.05). In the conventional group, 13 out of 87 patients (14.9%) had inappropriate prescriptions, and 2 out of 87 (2.3%) in the enterprise WeChat group, with statistically significant difference (χ2=8.828, P<0.05). After management with enterprise WeChat, the patients of pain-free increased from 19 to 55 (63.2%) in the enterprise WeChat group, and from 18 to 41 (47.1%) in the conventional group. The difference in the proportion of pain-free patients between the 2 groups was statistically significant (χ2=4.555, P=0.033). The differences in the scores of various indicators of life quality between the 2 groups before management with enterprise WeChat were not significant (all P>0.05). After the management with enterprise WeChat, life quality scores in all the 8 dimensions were significantly higher than those in the conventional group (all P<0.05). Conclusion The utilization of enterprise WeChat could improve the treatment effect of cancer pain, enhance their life quality, help improve the quality of pharmaceutical services, and have certain promotion and utilization value.
万方数据
